Bendamustine (Synonyms: SDX-105 free base)
目录号: PL03485 纯度: ≥98%
CAS No. :16506-27-7
商品编号 规格 价格 会员价 是否有货 数量
PL03485-5mg 5mg ¥1112.73 请登录
PL03485-10mg 10mg ¥1854.55 请登录
PL03485-25mg 25mg ¥4080.00 请登录
PL03485-50mg 50mg ¥6429.09 请登录
PL03485-100mg 100mg ¥10261.82 请登录
PL03485-200mg 200mg 询价 询价
PL03485-500mg 500mg 询价 询价
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
Bendamustine
中文别名
宾达氮芥;苯达莫司汀;4-[5-[双(2-氯乙基)氨基]-1-甲基苯并咪唑-2-基]丁酸;苯达莫司汀标准品;宾达氮芥,苯达莫司汀;甲基1,2-环戊烯环氧物;盐酸苯达莫司汀
英文名称
Bendamustine
英文别名
4-(5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid;5-(Bis(2-chloroethyl)amino)-1-methyl-2-benzimidazolebutyric acid;4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid;5-[bis(2-chloroethyl)amino]-1-methyl-1H-Benzimidazole-2-butanoic acid;Bendamustine;4-[5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl]butanoic acid;4-{5-[bis-(2-chloro-ethyl)-amino]-1-methyl-1H-benzoimidazol-2-yl}-butyric acid;4-{5-[bis(2-chloroethyl)amino]-1-methyl-2-benzimidazolyl} butyric acid;4-<1-Methyl-5-benzimidazolyl-(2)>butansaeure;Bendamustin;Bendamustina [Spanish];Bendamustine (INN);BENDAMUSTINE ,USP;Bendamustinum [Latin];SDX 105;Treanda (TN);UNII-9266D9P3PQ;4-(5-(Bis(2-chloroethyl);1H-BenziMidazole-2-butanoicacid, 5-[bis(2-chloroethyl)aMino]-1-Methyl-
Cas No.
16506-27-7
分子式
C16H21N3O2Cl2
分子量
358.26
包装储存
-20°C, protect from light In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
产品详情
Bendamustine (SDX-105 free base),一种嘌呤类似物,是一种 DNA 交联剂。Bendamustine 可激活 DNA 损伤反应和细胞凋亡 (apoptosis)。Bendamustine 具有有效的烷基化,抗癌和抗代谢作用。
生物活性
Bendamustine (SDX-105 free base), a purine analogue, is a DNA cross-linking agent. Bendamustine activates DNA-damage stress response and apoptosis. Bendamustine has potent alkylating, anticancer and antimetabolite properties.
性状
Solid
IC50 & Target[1][2]
DNA Alkylator/Crosslinker
体外研究(In Vitro)
Bendamustine is a DNA cross-linking agent that causes DNA breaks, with alkylating and antimetabolite properties. Bendamustine uniquely regulates apoptosis pathways and DNA repair pathways in non-Hodgkins lymphoma cells. Bendamustine (50 μM) induces p21 (Cip1/Waf1) and NOXA genes, and increases the expression of p53 in SU-DHL-1 cells. Bendamustine (25 μM) blocks mitotic checkpoints and cuases mitotic catastrophe.
Bendamustine reduces the viability of multiple myeloma (MM) cell lines, such as RPMI-8226 and 8226-LR5 cells, with IC25s of 101.8 μM and 585.5 μM after 24 h incubation, and 51.7 and 374.3 μM after 48 h incubation, respectively. Bendamustine induces a specific caspase-dependent MM cell death and inhibits the spindle-assembly checkpoint. has not independently confirmed the accuracy of these methods
体内研究(In Vivo)
Bendamustine (25 mg/kg, i.v.) shows potent inhibition on the growth of tumor cells by 91%, 99% and 95% for DoHH-2, Granta 519 and RAMOS models, respectively. Moreover, the antitumor effect of Bendamustine is enhanced by rituximab in DoHH-2 and RAMOS models, but not in Granta 519 model. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
-20°C, protect from light In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
ClinicalTrial
参考文献
[1]. Leoni LM, et al. Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents. Clin Cancer Res. 2008 Jan 1;14(1):309-17.
[2]. Cives M, et al. Bendamustine overcomes resistance to melphalan in myeloma cell lines by inducing cell death through mitotic catastrophe. Cell Signal. 2013 May;25(5):1108-17.
溶解度数据
In Vitro: DMSO : 100 mg/mL (279.13 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2